Gilca R, Deceuninck G, Lefebvre B, Tsang R, Amini R, Gilca V
PLoS One. 2012; 7(11):e50659.
PMID: 23209803
PMC: 3510192.
DOI: 10.1371/journal.pone.0050659.
Moodley C, du Plessis M, Ndlangisa K, de Gouveia L, Klugman K, von Gottberg A
J Clin Microbiol. 2012; 50(11):3678-86.
PMID: 22972827
PMC: 3486271.
DOI: 10.1128/JCM.01079-12.
Racloz V, Luiz S
BMC Infect Dis. 2010; 10:175.
PMID: 20565757
PMC: 2894839.
DOI: 10.1186/1471-2334-10-175.
Elias J, Schouls L, van de Pol I, Keijzers W, Martin D, Glennie A
Emerg Infect Dis. 2010; 16(3):465-72.
PMID: 20202422
PMC: 3322024.
DOI: 10.3201/eid1603.091102.
Sloan A, Henderson A, Tsang R
Can J Infect Dis Med Microbiol. 2009; 19(3):227-32.
PMID: 19412379
PMC: 2605869.
DOI: 10.1155/2008/523021.
Sequencing of the porB gene: a step toward a true characterization of Neisseria meningitidis.
Abad R, Alcala B, Salcedo C, Enriquez R, Uria M, Diez P
Clin Vaccine Immunol. 2006; 13(10):1087-91.
PMID: 17028211
PMC: 1595317.
DOI: 10.1128/CVI.00211-06.
High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002.
Smith I, Caugant D, Hoiby E, Wentzel-Larsen T, Halstensen A
Epidemiol Infect. 2006; 134(6):1195-202.
PMID: 16650328
PMC: 2870511.
DOI: 10.1017/S0950268806006248.
Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic.
Dyet K, Martin D
Epidemiol Infect. 2006; 134(2):377-83.
PMID: 16490143
PMC: 2870387.
DOI: 10.1017/S0950268805004954.
Stability of PorA during a meningococcal disease epidemic.
Devoy A, Dyet K, Martin D
J Clin Microbiol. 2005; 43(2):832-7.
PMID: 15695688
PMC: 548076.
DOI: 10.1128/JCM.43.2.832-837.2005.
Invasive meningococcal disease in Scotland, 1994 to 1999, with emphasis on group B meningococcal disease.
Kyaw M, Clarke S, Christie P, Jones I, Campbell H
J Clin Microbiol. 2002; 40(5):1834-7.
PMID: 11980971
PMC: 130913.
DOI: 10.1128/JCM.40.5.1834-1837.2002.
Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant.
Steeghs L, de Cock H, Evers E, Zomer B, Tommassen J, van der Ley P
EMBO J. 2001; 20(24):6937-45.
PMID: 11742971
PMC: 125796.
DOI: 10.1093/emboj/20.24.6937.
Neisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced upregulation of costimulatory ligand B7-2.
Bhasin N, Ho Y, Wetzler L
Infect Immun. 2001; 69(8):5031-6.
PMID: 11447183
PMC: 98597.
DOI: 10.1128/IAI.69.8.5031-5036.2001.
Molecular epidemiology of serogroup a meningitis in Moscow, 1969 to 1997.
Achtman M, van der Ende A, Zhu P, Koroleva I, Kusecek B, Morelli G
Emerg Infect Dis. 2001; 7(3):420-7.
PMID: 11384519
PMC: 2631801.
DOI: 10.3201/eid0703.010309.
Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis.
Zhu P, van der Ende A, Falush D, Brieske N, Morelli G, Linz B
Proc Natl Acad Sci U S A. 2001; 98(9):5234-9.
PMID: 11287631
PMC: 33193.
DOI: 10.1073/pnas.061386098.
Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts.
Tzanakaki G, Urwin R, Musilek M, Kriz P, Kremastinou J, Pangalis A
J Clin Microbiol. 2001; 39(4):1235-40.
PMID: 11283034
PMC: 87917.
DOI: 10.1128/JCM.39.4.1235-1240.2001.
NmeSI restriction-modification system identified by representational difference analysis of a hypervirulent Neisseria meningitidis strain.
Bart A, Pannekoek Y, Dankert J, van der Ende A
Infect Immun. 2001; 69(3):1816-20.
PMID: 11179359
PMC: 98088.
DOI: 10.1128/IAI.69.3.1816-1820.2001.
Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.
Tondella M, Popovic T, Rosenstein N, Lake D, Carlone G, Mayer L
J Clin Microbiol. 2000; 38(9):3323-8.
PMID: 10970378
PMC: 87381.
DOI: 10.1128/JCM.38.9.3323-3328.2000.
The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.
Fijen C, Bredius R, Kuijper E, Out T, de Haas M, De Wit A
Clin Exp Immunol. 2000; 120(2):338-45.
PMID: 10792385
PMC: 1905639.
DOI: 10.1046/j.1365-2249.2000.01208.x.
Update on meningococcal disease with emphasis on pathogenesis and clinical management.
van Deuren M, Brandtzaeg P, van der Meer J
Clin Microbiol Rev. 2000; 13(1):144-66, table of contents.
PMID: 10627495
PMC: 88937.
DOI: 10.1128/CMR.13.1.144.
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
Moe G, Tan S, Granoff D
Infect Immun. 1999; 67(11):5664-75.
PMID: 10531214
PMC: 96940.
DOI: 10.1128/IAI.67.11.5664-5675.1999.